Registro:

Referencias:

• Feldmann, M., Brennan, F.M., Abney, E.R., Are imbalances in cytokine function of importance in the pathogenesis of rheumatoid arthritis? (1994) Immunopharmacology of Joints and Connective Tissue, pp. 119-128. , Davies ME, Dingle JT, editors. London: Academic Press
• Feldmann, M., Brennan, F.M., Maini, R.N., Role of cytokines in rheumatoid arthritis (1996) Ann Rev Immunol, 14, pp. 397-440
• Deighton, C.M., Wentzel, J., Cavanagh, G., Contribution of inherited factors to rheumatoid arthritis (1992) Ann Rheum Dis, 51, pp. 182-185
• Stastny, P., Association of the B-cell alloantigen Drw4 with rheumatoid arthritis (1978) N Engl J Med, 298, pp. 869-872
• Winchester, R., The molecular basis of susceptibility to rheumatoid arthritis (1994) Adv Immunol, 56, pp. 389-450
• Londei, M., Persistence of collagen type II specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis (1989) Proc Natl Acad Sci U S A, 86, pp. 636-640
• Gause, A., Gundlach, K., Zdichavsky, M., The B-lymphocyte in rheumatoid-arthritis - Analysis of rearranged V-kappa genes from B-cells infiltrating the synovial-membrane (1995) Eur J Immunol, 25, pp. 2775-2782
• Moyes, S.P., Brown, C.M., Scott, B.B., Analysis of Vk genes in rheumatoid arthritis synovial B lymphocytes provides evidence for both polyclonal activation and antigen-driven selection (1996) Clin Exp Immunol, 105, pp. 89-98
• Hingorani, R., Monteiro, J., Furie, R., Oligoclonality of V-beta-3 TCR chains in the CD8(+) T-cell population of rheumatoid-arthritis patients (1996) J Immunol, 156, pp. 852-858
• Paliard, X., West, S.G., Lafferty, J.A., Evidence for the effects of a superantigen in rheumatoid arthritis (1991) Science, 253, pp. 325-329
• Brennan, F.M., Chantry, D., Jackson, A., Inhibitory effect of TNF antibodies on synovial cell IL-1 production in rheumatoid arthritis (1989) Lancet, 11, pp. 244-247
• Haworth, C., Brennan, F.M., Chantry, D., Expression of granulocyte-macrophage colony stimulating factor (GM-CSF) in rheumatoid arthritis: Regulation by tumour necrosis factor alpha (1991) Rheumatol Int, 11, pp. 45-50
• McInnes, I.B., Leung, B.P., Sturrock, R.D., IL-15 mediates T cell-dependent regulation of TNFα production in rheumatoid arthritis (1997) Nat Med, 3, pp. 189-195
• Holmdahl, R., Jansson, L., Larsson, E., Homologous type II collagen induces chronic and progressive arthritis in mice (1986) Arthritis Rheum, 29, pp. 106-113
• Holmdahl, R., Mo, J., Nordling, C., Collagen induced arthritis: An experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms (1989) Clin Exp Rheumatol, 7 (3 SUPPL.), pp. 51-55
• Courtenay, J.S., Dallman, M.J., Dayan, A.D., Immunisation against type II collagen induces arthritis in mice (1980) Nature, 283, pp. 665-668
• Elliott, M., Maini, R.N., Feldmann, M., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF alpha (1993) Arthritis Rheum, 36, pp. 1681-1689
• Elliott, M.J., Maini, R.N., Feldmann, M., Randomised double blind comparison of a chimaeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis (1994) Lancet, 344, pp. 1105-1110
• Seki, N., Sudo, Y., Yoshioka, T., Type II-induced murine arthritis. I. Induction and preparation of arthritis require synergy between humoral and cell mediated immunity (1988) J Immunol, 140, pp. 1477-1484
• Nabozny, G.H., Baisch, J.M., Cheng, S., HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: A novel model for human polyarthritis (1996) J Exp Med, 183, pp. 27-37
• Gonzalez-Gay, M.A., Nabozny, G.H., Bull, M.J., Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis (1994) J Exp Med, 180, pp. 1559-1564
• Mori, L., Loetscher, H., Kakimoto, K., Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis (1992) J Exp Med, 176, pp. 381-388
• Osman, G.E., Toda, M., Kanagawa, O., Characterization of the T cell receptor repertoire causing collagen arthritis in mice (1993) J Exp Med, 177, pp. 387-395
• Banerjee, S., Anderson, G.D., Luthra, H.S., Influence of complement C5 and V-beta T cell receptor mutation on susceptibility to collagen-induced arthritis in mice (1989) J Immunol, 142, pp. 2237-2243
• Keffer, J., Probert, L., Cazlaris, H., Transgenic mice expressing human TNF: A predictive genetic model of arthritis (1991) EMBO J, 10, pp. 4025-4031
• McIntyre, K.W., Shuster, D.J., Gillooly, K.M., Reduced incidence and severity of collagen-induced arthritis in IL-12 deficient mice (1996) Eur J Immunol, 26, pp. 2933-2938
• Hess, H., Gately, M.K., Rüde, E., High doses of IL-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant (1996) Eur J Immunol, 26, pp. 187-191
• Williams, R.O., Mason, E.J., Feldmann, M., Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis (1994) Proc Natl Acad Sci U S A, 91, pp. 2762-2766
• Williams, R.O., Feldmann, M., Maini, R.N., Anti-TNF ameliorates joint disease in murine collagen-induced arthritis (1992) Proc Natl Acad Sci U S A, 89, pp. 9784-9788
• Kasama, T., Strieter, R.M., Lukacs, N.W., IL-10 expression and chemokine regulation during the evolution of murine type I collagen-induced arthritis (1995) J Clin Invest, 95, pp. 2868-2876
• Durie, F.H., Fava, R.A., Foy, T.M., Prevention of collagen induced arthritis with an antibody to gp39, the ligand to CD40 (1993) Science, 261, pp. 1328-1330
• Webb, L., Walmsley, M.J., Feldmann, M., Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 costimulatory pathway - Requirement for both B7-1 and B7-2 (1996) Eur J Immunol, 26, pp. 2320-2328
• Mikecz, K., Brennan, F.R., Kim, J.H., Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis (1995) Nat Med, 1, pp. 558-563
• Kavanaugh, A., Nichols, L., Davis, L., Anti-CD54 (ICAM-1) monoclonal antibody therapy in refractory rheumatoid arthritis (1993) Arthritis Rheum, 36, pp. S40
• Ilgo, Y., Takashi, T., Tamatani, T., ICAM-1 dependent pathway is critically involved in the pathogenesis of adjuvant arthritis (1991) J Immunol, 147, pp. 4167-4171
• Plater-Zyberk, C., Bonnefoy, J.-Y., Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo (1995) Nat Med, 1, pp. 781-785
• Wang, Y., Rollins, S.A., Madri, J.A., Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease (1995) Proc Natl Acad Sci U S A, 92, pp. 8955-8959
• Malfait, A.-M., Butler, D., Presky, D.H., Blockade of IL-12 during the induction of collagen-induced arthritis markedly attenuates the severity of the arthritis Clin Exp Immunol., , In press
• Lens, J.W., Van Der Bers, W.B., Van De Putte, L.B., Flare-up of antigen induced arthritis in mice after challenge with intravenous antisera: Effects of pretreatment with cobra venom factor and anti-lymphocyte antiserum (1984) Clin Exp Immunol, 3, pp. 520-528
• Lanzavechia, A., Identifying strategies for immune intervention (1993) Science, 260, pp. 937-944
• Lifely, M.R., Hale, C., Boyce, S., Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions (1995) Glycobiology, 5, pp. 813-822
• Gossen, M., Freundlieb, S., Bender, G., Transcriptional activation by tetracyclines in mammalian cells (1995) Science, 268, pp. 1766-1769
• Bohl, D., Naffakh, N., Heard, J.-M., Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts (1997) Nat Med, 3, pp. 299-305
• Colcher, D., Bird, R., Roselli, M., In vivo tumor targeting of a recombinant single-chain antigen-binding protein (1990) J Natl Cancer Inst, 82, pp. 1191-1197
• Yokota, T., Milenic, D.E., Whitlow, M., Rapid tumor penetration of single-chain Fv and comparison with other immunoglobulin forms (1992) Cancer Res, 52, pp. 3402-3408
• McCafferty, J., Griffiths, A.D., Winter, G., Phage antibodies: Filamentous phage displaying antibody variable domains (1990) Nature, 348, pp. 552-554
• Deshane, J., Grim, J., Feng, M., Targeted eradication of erbB-2 over-expressing tumor-cells employing expression of an intracellular antibody-directed against the erbB-2 oncoprotein (1995) Eur J Cancer, 31 A, p. 21
• Biocca, S., Cattanea, A., Intracellular immunization: Antibody targeting to subcellular compartments (1995) Trends Cell Biol, 5, pp. 248-252
• Speiser, D.E., Sebzda, E., Ohteki, T., Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo (1996) Eur J Immunol, 26, pp. 3055-3060
• Williams, R.O., Ghrayeb, J., Feldmann, M., Successful therapy of collagen induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4 (1995) Immunology, 84, pp. 433-439
• Baker, D., Butler, D., Scallon, B.J., Control of established EAE by inhibition of TNF activity within the CNS using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins (1994) Eur J Immunol, 24, pp. 2040-2048
• Moreland, L.W., Margolies, G., Heck Jr., L.W., Recombinant soluble TNF-R (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis (1996) J Rheumatol, 23, pp. 1849-1855
• Peppel, K., Crawford, D., Beutler, B., A TNF receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity (1991) J Exp Med, 174, pp. 1483-1489
• Bemelmans, M.H.A., Gouma, D.J., Buurman, W.A., Influence of nephrectomy on TNF receptor clearance in a murine model (1993) J Immunol, 150, pp. 2007-2017
• Nophar, Y., Kemper, O., Brakebusch, C., Soluble forms of tumour necrosis factor receptors (TNF-Rs): The cDNA for type 1 TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor (1990) EMBO J, 9, pp. 3269-3278
• Chernajovsky, Y., Adams, G., Podhajcer, O., Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble human TNF receptor (1995) Gene Ther, 2, pp. 731-735
• Neve, R., Kissonerghis, M., Feldmann, M., Expression of an efficient small molecular weight TNF/lymphotoxin antagonist (1996) Cytokine, 8, pp. 365-370
• Chernajovsky, Y., Systemic gene therapy of arthritis Innovative Therapies for Rheumatoid Arthritis, , Robbins PD, Evans C, editors. Barcelona: Prous Science. In press
• Croxford, J.L., Baker, D., Triantaphyllopoulos, K., Cytokine gene therapy in chronic relapsing experimental allergic encephalomyelitis (1996) Multiple Sclerosis, 2, p. 20
• Sioud, M., Natvig, J.B., Forre, O., Preformed ribozyme destroys tumor-necrosis-factor messenger RNA in human cells (1992) J Mol Biol, 223, pp. 831-835
• Sioud, M., Interaction between tumor-necrosis-factor-alpha ribozyme and cellular proteins - Involvement in ribozyme stability and activity (1994) J Mol Biol, 242, pp. 619-629
• Wooley, P.H., Whalen, J.D., Chapman, D.L., The effect of an IL-1ra protein on type II collagen-induced arthritis and antigen-induced arthritis in mice (1993) Arthritis Rheum, 36, pp. 1305-1314
• Hung, G.L., Galea-Lauri, J., Mueller, G.M., Suppression of intra-articular responses to IL-1 by transfer of the IL-1 receptor antagonist gene to synovium (1994) Gene Ther, 1, pp. 64-69
• Bandara, G., Mueller, G.M., Galea-Lauri, J., Intraarticular expression of biologically active IL-1 receptor antagonist protein by ex vivo gene transfer (1993) Proc Natl Acad Sci U S A, 90, pp. 10764-10768
• Makarov, S.S., Olsen, J.C., Johnston, W.N., Suppression of experimental arthritis by gene-transfer of IL-1 receptor antagonist cDNA (1996) Proc Natl Acad Sci U S A, 93, pp. 402-406
• Otani, K., Nita, I., Macaulay, W., Suppression of antigen-induced arthritis in rabbits by ex vivo gene-therapy (1996) J Immunol, 56, pp. 3558-3562
• Ghivizzani, S.C., Kang, R., Hatton, C., In vivo delivery of genes encoding soluble receptors for IL-1 and TNF-alpha results in a synergistic therapeutic effect in antigen-induced arthritis in the rabbit knee (1996) Arthritis Rheum, 39, pp. S308
• Evans, C.H., Robbins, P.D., Ghivizzani, S.C., Clinical trial to assess safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis (1996) Hum Gene Ther, 7, pp. 1261-1280
• Symons, J.A., Young, P.R., Duff, G.W., Soluble type-ii interleukin-1 (IL-1) receptor binds and blocks processing of IL-1-beta precursor and loses affinity for IL-1 receptor antagonist (1995) Proc Natl Acad Sci U S A, 92, pp. 1714-1718
• Mosmann, T.R., Coffman, R.L., Heterogeneity of cytokine secretion patterns and functions of helper T cells (1989) Adv Immunol, 46, pp. 111-147
• Mosmann, T.R., Sad, S., The expanding universe of T-cell subsets: Th1, Th2 and more (1996) Immunol Today, 17, pp. 138-146
• D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., IL-10 inhibits human lymphocyte IFN-gamma-production by suppressing natural killer cell stimulatory factor IL-12 synthesis in accessory cells (1993) J Exp Med, 178, pp. 1041-1048
• Walmsley, M., Katsikis, P.D., Abney, E., Interleukin-10 inhibition of the progression of established collagen-induced arthritis (1996) Arthritis Rheum, 39, pp. 495-503
• Del Prete, G., De Carli, M., Almerigogna, F., Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production (1993) J Immunol, 150, pp. 353-360
• Perez, L., Orte, J., Brieva, J.A., Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous IL-10 (1995) Arthritis Rheum, 38, pp. 1771-1776
• Bessis, N., Boissier, M.C., Caput, D., Cytokine gene-therapy using IL-4 and IL-13 in murine collagen-induced arthritis (1994) Clin Res, 42, pp. A135
• Bessis, N., Boissier, M.C., Ferrara, P., Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete IL-13 (1996) Eur J Immunol, 26, pp. 2399-2403
• Hesse, M., Bayrak, S., Mitchison, A., Protective major histocompatibility complex genes and the role of IL-4 in collagen induced arthritis (1996) Eur J Immunol, 26, pp. 3234-3237
• Erb, K.J., Rüger, B., Von Brevern, M., Constitutive expression of IL-4 in vivo causes autoimmune-type disorders in mice (1997) J Exp Med, 185, pp. 329-339
• Lewis, D.B., Liggitt, H.D., Effmann, E.L., Osteoporosis induced in mice by overproduction of IL-4 (1993) Proc Natl Acad Sci U S A, 90, pp. 11618-11622
• Marcelleti, J.F., Katz, D.H., Collagen-induced arthritis in mice: Relationship of collagen-specific and total IgE synthesis to disease (1991) J Immunol, 147, pp. 4185-4191
• Shull, M.M., Ormsby, I., Kier, A.B., Targeted disruption of the mouse TGF-beta1 gene results in multifocal inflammatory disease (1992) Nature, 359, pp. 693-699
• Arsura, M., Wu, M., Soneshein, G., TGF b1 inhibits NF-kB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IkBa (1996) Immunity, 5, pp. 31-40
• Fontana, A., Constam, D.B., Frei, K., Modulation of the immune response by TGF beta (1992) Int Arch Allergy Immunol, 99, pp. 1-7
• Günther, M., Haubeck, H.-D., Van De Leur, E., TGFb1 regulates TIMP-1 expression in differentiated articular chondrocytes (1994) Arthitis Rheum, 37, pp. 395-405
• Morales, T.I., Roberts, A.B., TGF beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures (1988) J Biol Chem, 263, pp. 12828-12831
• Derynck, R., Structure of TGF alpha and beta and their precursors (1987) Oncogenes, Genes and Growth Factors, pp. 133-163. , Guroff G, editor. New York: Academic Press
• Barcellos-Hoff, M.H., Derynck, R., Tsang, M.L., TGF beta activation in irradiated murine mammary gland (1994) J Clin Invest, 93, pp. 892-899
• Brandes, M.E., Allen, J.B., Ogawa, Y., TGF beta1 suppresses acute and chronic arthritis in experimental animals (1991) J Clin Invest, 87, pp. 1108-1113
• Kuruvilla, A.P., Shah, R., Hochwald, G.M., Protective effect of TGF beta1 on experimental autoimmune diseases in mice (1991) Proc Natl Acad Sci U S A, 88, pp. 2918-2921
• Allen, J.B., Manthey, C.L., Hand, A.R., Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor b (1990) J Exp Med, 171, pp. 231-247
• Raz, E., Dudler, J., Lotz, M., Modulation of disease activity in murine lupus erythematosus by cytokine gene delivery (1995) Lupus, 4, pp. 286-292
• Giladi, E., Raz, E., Karmeli, F., TGFb gene therapy ameliorates experimental colitis in rats (1995) Eur J Gastroenterol Hepatol, 7, pp. 341-347
• Chernajovsky, Y., Adams, G., Triantaphyllopoulos, K., Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model (1997) Gene Ther, 4, pp. 553-559
• Mihara, M., Ikuta, M., Koishihara, Y., IL-6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis (1991) Eur J Immunol, 21, pp. 2327-2331
• Aderka, D., Le, J., Vilcek, J., IL-6 inhibits LPS-induced TNF production in cultured human monocytes, U937 cells, and in mice (1989) J Immunol, 143, pp. 3517-3523
• Schindler, R., Mancilla, J., Endres, S., Correlations and interactions in the production of IL-6, IL-1 and TNF in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF (1990) Blood, 75, pp. 40-47
• Tilg, H., Trehu, E., Atkins, M.B., IL-6 as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble TNF receptor p55 (1994) Blood, 83, pp. 113-118
• Lotz, M., Guerne, P.-A., Interleukin-6 induces synthesis of tissue inhibitor of metalloproteinases (1991) J Biol Chem, 266, pp. 2017-2020
• Devajyothi, C., Kalvakolanu, I., Babcock, G.T., Inhibition of IFN gamma-induced MHC class II gene transcription by IFN beta and TGF beta1 in human astrocytoma cells (1993) J Biol Chem, 268, pp. 18794-18800
• Fearon, D.T., Carter, R.H., The CD19/CR2/tapa-1 complex of B lymphocytes: Linking natural to acquired immunity (1995) Ann Rev Immunol, 13, pp. 127-149
• Weisman, H.F., Bartow, T., Leppo, M.K., Soluble human complement receptor 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis (1990) Science, 249, pp. 146-151
• Mulligan, R., The basic science of gene therapy (1993) Science, 260, pp. 926-932
• Riddel, S.R., Elliott, M., Lewinsohn, D.A., T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients (1996) Nat Med, 2, pp. 216-223
• Dai, Y., Schwarz, E.M., Gu, D., Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression (1995) Proc Natl Acad Sci U S A, 92, pp. 1401-1405
• Wilson, J.M., Adenoviruses as gene delivery vehicles (1996) N Engl J Med, 334, pp. 1185-1187
• Takeuchi, Y., Porter, C.D., Strahan, K.M., Sensitization of cells and retroviruses to human serum by (alpha-1-3) galactosyl transferase (1996) Nature, 379, pp. 85-88
• Naldini, L., Blömer, U., Gallay, P., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector (1996) Science, 272, pp. 263-267
• Nilson, B., Morling, F.J., Cosset, F.L., Targeting of retroviral vectors through protease-substrate interactions (1996) Gene Ther, 3, pp. 280-286
• Cosset, F.L., Morling, F.J., Takeuchi, Y., Retroviral retargeting by envelopes expressing an N-terminal binding domain (1995) J Virol, 69, pp. 6314-6322
• Cosset, F.L., Russell, S.J., Targeting retrovirus entry (1996) Gene Ther, 3, pp. 946-956
• Kozarsky, K.F., Wilson, J.M., Gene therapy: Adenovirus vectors (1993) Curr Opin Genet Dev, 3, pp. 499-503
• Gorziglia, M.I., Kadan, M.J., Yei, S., Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy (1996) J Virol, 70, pp. 4173-4178
• Flotte, T.R., Carter, B.J., Adeno-associated virus vectors for gene therapy (1995) Gene Ther, 2, pp. 357-362
• Chernajovsky, Y., Feldmann, M., Maini, R.N., Gene therapy of rheumatoid arthritis via cytokine regulation: Future perspectives (1995) Br Med Bull, 51, pp. 503-516
• Xiang, Z., Ertl, H.C.J., Manipulation of the immune response to a plasmid encoded viral antigen by co-inoculation with plasmids expressing cytokines (1995) Immunity, 2, pp. 129-135
• Hsu, C.-H., Chua, K.-Y., Tao, M.-H., Immunoprophylaxis of allergen-induced IgE synthesis and airway hyperresponsiveness in vivo by genetic immunization (1996) Nat Med, 2, pp. 540-544
• Nabel, G.J., Gordon, D., Bishop, D.K., Immune response in human melanoma after transfer of an allogeneic class I MHC gene with DNA-liposome complexes (1996) Proc Natl Acad Sci U S A, 93, pp. 15388-15393
• Hakim, I., Levy, S., Levy, R., A nine amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines (1996) J Immunol, 157, pp. 5503-5511
• Makurov, S.S., Baldwin, A.S., Local suppression of NFkB inhibits experimental arthritis in rats (1996) Arthritis Rheum, 39, p. 563
• Tomita, T., Hashimoto, H., Tomita, N., Potential gene therapy tor rheumatoid arthritis - Transfection of NFkB decoy inhibited production of interleukin-1 from synovial tissue of patients with rheumatoid arthritis (1996) Arthritis Rheum, 39, p. 577
• Makarov, S.S., Johnston, W.N., Olsen, J.C., Gene-transfer of IkBα inhibits inflammatory responses in monocytic and stromal cells (1996) J Leukoc Biol, p. 289
• Wrighton, C.J., Hofer-Warbinek, R., Moll, T., Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBa, an inhibitor of the transcription factor NF-kB (1996) J Exp Med, 183, pp. 1013-1022
• Neurath, M.F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice (1996) Nat Med, 2, pp. 998-1004
• Bandara, G., Robbins, P.D., Georgescu, H.I., Gene transfer to synoviocytes: Prospects for gene treatment of arthritis (1992) DNA Cell Biol, 11, pp. 227-231
• Makarov, S.S., Olsen, J.C., Johnston, W.N., Retrovirus-mediated in vivo gene-transfer to synovium in bacterial cell wall-induced arthritis in rats (1995) Gene Ther, 2, pp. 424-428
• Nita, I., Ghivizzani, S.C., Galealauri, J., Direct gene delivery to synovium - An evaluation of potential vectors in vitro and in vivo (1996) Arthritis Rheum, 39, pp. 820-828
• Roessler, B.J., Allen, E.D., Wilson, J.M., Adenoviral-mediated gene transfer to rabbit synovium in vivo (1993) J Clin Invest, 92, pp. 1085-1092
• Firestein, G.S., Nguyen, K., Aupperle, K.R., Apoptosis in rheumatoid arthritis - p53 overexpression in rheumatoid arthritis synovium (1996) Am J Pathol, 149, pp. 2143-2151
• Gay, S., Huang, G.-Q., Ziegler, B., Expression of myb, myc, ras and fos oncogenes in synovial cells of patients with rheumatoid arthritis or osteoarthritis (1989) Arthritis Rheum, 32 (SUPPL.), p. 59
• Isomaki, P., Soderstrom, K.O., Punnonen, J., Expression of bcl-2 in rheumatoid arthritis (1996) Br J Rheumatol, 35, pp. 611-619
• Roivainen, A., Soderstrom, K.O., Pirila, L., Oncoprotein expression in human synovial tissue - An immunohistochemical study of different types of arthritis (1996) Br J Rheumatol, 35, pp. 933-942
• Roivainen, A., Jalava, J., Pirila, L., H-ras oncogene point mutations in arthritic synovium (1996) Arthritis Rheum, 40, pp. 1636-1643
• Berenblum, I., The mechanisms of carcinogenesis - A study of the significance of co-carcinogenic action and related phenomena (1981) Cancer J Clinicians, 31, pp. 241-253
• Baragi, V.M., Renkiewicz, R.R., Jordan, H., Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation (1995) J Clin Invest, 96, pp. 2454-2460

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------